Magnetic Resonance Imaging and Serum AFP-L3 and GP-73 in the Diagnosis of Primary Liver Cancer

Objective. To investigate the combined application value of magnetic resonance imaging (MRI) combined with serum alpha-fetoprotein (AFP)-L3 and Golgi protein (GP)-73 in the diagnosis of primary liver cancer. Methods. The data of 200 patients with suspected liver cancer admitted to our hospital from...

Full description

Saved in:
Bibliographic Details
Published in:Journal of oncology 2022, Vol.2022, p.1192368-7
Main Authors: Yuan, Jun-Jian, Xu, Yan-Dong, Li, Heng, Guo, Qing-Jin, Li, Guo-Ce, Chai, Wei, Zhang, Zhi-Quan, Liu, Ru-Hai
Format: Article
Language:English
Subjects:
Abdomen
Alpha fetoproteins
Business insurance
CT imaging
Gender
Liver cancer
Magnetic resonance imaging
Medical diagnosis
Medical imaging
Methods
Pharmaceuticals
Serology
Tumors
Ultrasonic imaging
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective. To investigate the combined application value of magnetic resonance imaging (MRI) combined with serum alpha-fetoprotein (AFP)-L3 and Golgi protein (GP)-73 in the diagnosis of primary liver cancer. Methods. The data of 200 patients with suspected liver cancer admitted to our hospital from February 2020 to February 2021 were retrospectively analyzed, and they were randomly divided into an experimental group and a control group, with 100 cases in each group. The experimental group received a combined detection of MRI with serum AFP-L3 and GP-73, and the control group adopted traditional diagnostic methods (spiral computed tomography and serum AFP). The diagnostic yields of the two groups were compared. Surgical resection was performed after the diagnosis of primary liver cancer, and the correlation between the efficacy and combined detection of MRI with serum AFP-L3 and GP-73 levels was analyzed. Results. The two groups presented comparable general information (P >0.05). The surgical results showed 160 cases of primary liver cancer, including 75 cases in the experimental group and 85 cases in the control group, and 40 cases of benign liver lesions. The diagnostic accuracy of the experimental group (73/75, 95%) was significantly higher than that of the control group (76/85, 86%) (P
ISSN:1687-8450
1687-8450
1687-8469
DOI:10.1155/2022/1192368